TRILACICLIB

TRILACICLIB was reported 244 times

These side effects are most commonly reported by patients taking TRILACICLIB:

# Side effect Count
0 MYELOSUPPRESSION 37
1 OFF LABEL USE 27
2 DYSPNOEA 19
3 WHITE BLOOD CELL COUNT DECREASED 19
4 PLATELET COUNT DECREASED 18
5 DEATH 16
6 PNEUMONIA 15
7 ANAEMIA 14
8 PERFORMANCE STATUS DECREASED 14
9 FATIGUE 13
10 NAUSEA 13
11 INFECTION 12
12 CHEST DISCOMFORT 11
13 HAEMORRHAGE 11
14 INFUSION SITE PAIN 11
15 RED BLOOD CELL COUNT DECREASED 11
16 SEPSIS 11
17 ASTHENIA 10
18 COUGH 10
19 PAIN 9
20 ALOPECIA 8
21 ANXIETY 8
22 DEPRESSED MOOD 8
23 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8
24 MALAISE 8
25 NERVOUSNESS 8
26 NEUTROPHIL COUNT DECREASED 8
27 PHLEBITIS 8
28 PSYCHIATRIC SYMPTOM 8
29 PYREXIA 8
30 SOMNOLENCE 8
31 WEIGHT DECREASED 8
32 FEAR OF DEATH 7
33 NEUTROPENIA 7
34 ALANINE AMINOTRANSFERASE INCREASED 6
35 DIZZINESS 6
36 VOMITING 6
37 BURNING SENSATION 5
38 HEADACHE 5
39 INFUSION SITE ERYTHEMA 5
40 INJECTION SITE REACTION 5
41 RASH 5
42 DRUG INEFFECTIVE 4
43 FEBRILE NEUTROPENIA 4
44 INFUSION SITE IRRITATION 4
45 INJECTION SITE PAIN 4
46 BICYTOPENIA 3
47 CARDIAC FAILURE 3
48 DECREASED APPETITE 3
49 DIARRHOEA 3
50 ERYTHEMA 3
51 FLUSHING 3
52 HYPERTENSION 3
53 HYPOKALAEMIA 3
54 RESPIRATORY DISORDER 3
55 SYNCOPE 3
56 ABDOMINAL PAIN 2
57 ANAPHYLACTIC REACTION 2
58 ASPARTATE AMINOTRANSFERASE INCREASED 2
59 ATRIAL FIBRILLATION 2
60 CARDIAC FAILURE ACUTE 2
61 CARDIAC FAILURE CHRONIC 2
62 CHEST PAIN 2
63 CONSTIPATION 2
64 COVID-19 2
65 DEEP VEIN THROMBOSIS 2
66 DEHYDRATION 2
67 DISEASE PROGRESSION 2
68 EPISTAXIS 2
69 EXTRAVASATION 2
70 FEBRILE BONE MARROW APLASIA 2
71 GRANULOCYTE COUNT DECREASED 2
72 HOT FLUSH 2
73 HYPERSENSITIVITY 2
74 HYPOAESTHESIA 2
75 HYPONATRAEMIA 2
76 INCORRECT DOSE ADMINISTERED 2
77 INFECTIOUS PLEURAL EFFUSION 2
78 INFUSION RELATED REACTION 2
79 INFUSION SITE REACTION 2
80 INJECTION SITE ERYTHEMA 2
81 INJECTION SITE EXTRAVASATION 2
82 INSOMNIA 2
83 LEUKOPENIA 2
84 LOSS OF CONSCIOUSNESS 2
85 METASTASES TO CENTRAL NERVOUS SYSTEM 2
86 MUSCLE SPASMS 2
87 NEUROPATHY PERIPHERAL 2
88 PALPITATIONS 2
89 PNEUMONITIS 2
90 PRODUCT DOSE OMISSION ISSUE 2
91 PRODUCT USE IN UNAPPROVED INDICATION 2
92 PULMONARY EMBOLISM 2
93 RESPIRATORY FAILURE 2
94 THERAPEUTIC PRODUCT EFFECT DECREASED 2
95 THROMBOCYTOPENIA 2
96 TISSUE INFILTRATION 2
97 ABNORMAL WEIGHT GAIN 1
98 ACUTE RESPIRATORY FAILURE 1
99 ADMINISTRATION SITE REACTION 1
100 ADVERSE EVENT 1
101 ADVERSE REACTION 1
102 AGITATION 1
103 ARTHRALGIA 1
104 BLOOD ALBUMIN DECREASED 1
105 BLOOD CALCIUM DECREASED 1
106 BLOOD PHOSPHORUS DECREASED 1
107 BRAIN INJURY 1
108 CARDIAC DISORDER 1
109 CEREBRAL INFARCTION 1
110 CEREBRAL THROMBOSIS 1
111 CHROMATURIA 1
112 COLORECTAL CANCER METASTATIC 1
113 COMA 1
114 CONFUSIONAL STATE 1
115 CYTOPENIA 1
116 DEVICE RELATED THROMBOSIS 1
117 DIPLOPIA 1
118 DISCOMFORT 1
119 DRUG ERUPTION 1
120 DRUG HYPERSENSITIVITY 1
121 DRUG-INDUCED LIVER INJURY 1
122 ELECTROCARDIOGRAM QT PROLONGED 1
123 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
124 EXPOSURE VIA SKIN CONTACT 1
125 FACE OEDEMA 1
126 FAILURE TO THRIVE 1
127 FALL 1
128 FRUSTRATION TOLERANCE DECREASED 1
129 GAIT DISTURBANCE 1
130 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
131 GASTROINTESTINAL HAEMORRHAGE 1
132 GASTROINTESTINAL OBSTRUCTION 1
133 GENERAL PHYSICAL HEALTH DETERIORATION 1
134 HAEMOGLOBIN DECREASED 1
135 HAEMOPTYSIS 1
136 HEART RATE INCREASED 1
137 HEPATIC ENZYME INCREASED 1
138 HEPATIC FUNCTION ABNORMAL 1
139 HYPERCALCAEMIA 1
140 HYPERPYREXIA 1
141 HYPOPHOSPHATAEMIA 1
142 HYPOPITUITARISM 1
143 HYPOTHYROIDISM 1
144 ILEUS 1
145 ILL-DEFINED DISORDER 1
146 IMMUNE-MEDIATED MYOSITIS 1
147 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
148 INCORRECT DOSAGE ADMINISTERED 1
149 INFUSION SITE EXTRAVASATION 1
150 INJECTION SITE DISCOLOURATION 1
151 INJECTION SITE DISCOMFORT 1
152 INJECTION SITE IRRITATION 1
153 INTENTIONAL DOSE OMISSION 1
154 INTERCEPTED MEDICATION ERROR 1
155 INTESTINAL SEPSIS 1
156 KLEBSIELLA INFECTION 1
157 LIVER FUNCTION TEST ABNORMAL 1
158 MEDICATION ERROR 1
159 MENTAL DISORDER 1
160 MUCOSAL INFLAMMATION 1
161 MUSCULOSKELETAL STIFFNESS 1
162 MYOSITIS 1
163 NEAR DEATH EXPERIENCE 1
164 NEUROTOXICITY 1
165 NON-CARDIAC CHEST PAIN 1
166 OXYGEN SATURATION DECREASED 1
167 PAIN IN EXTREMITY 1
168 PANCYTOPENIA 1
169 PARAESTHESIA 1
170 PERIPHERAL SENSORY NEUROPATHY 1
171 PHYSICAL DECONDITIONING 1
172 PLEURAL EFFUSION 1
173 PNEUMONIA BACTERIAL 1
174 PRESYNCOPE 1
175 PROCEDURAL ANXIETY 1
176 PRODUCT PREPARATION ERROR 1
177 PRODUCT PRESCRIBING ISSUE 1
178 PRODUCT QUALITY ISSUE 1
179 PRODUCT STORAGE ERROR 1
180 PROTEIN TOTAL DECREASED 1
181 PROTEINURIA 1
182 PRURITUS 1
183 PULMONARY FIBROSIS 1
184 PULMONARY THROMBOSIS 1
185 PULSE ABSENT 1
186 RENAL FAILURE 1
187 RENAL INJURY 1
188 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 1
189 SKIN BURNING SENSATION 1
190 SKIN WARM 1
191 STOMATITIS 1
192 STRESS 1
193 SUDDEN DEATH 1
194 SWELLING 1
195 SWELLING FACE 1
196 TACHYPNOEA 1
197 TRANSAMINASES INCREASED 1
198 TREMOR 1
199 UNDERDOSE 1
200 UNEVALUABLE EVENT 1
201 URINARY TRACT INFECTION 1
202 UROSEPSIS 1
203 VEIN DISORDER 1
204 VISUAL IMPAIRMENT 1
205 WRONG SCHEDULE 1
206 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1